News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Paras Gupta, MBE

Articles by Paras Gupta, MBE

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
Published: February 3rd 2025 | Updated:

Trending on Psychiatric Times

FDA Issues Removal of Suicidal Behavior and Ideation Warning From GLP-1 RAs

Demystifying Artificial Intelligence: Understanding the Mechanism Behind the Magic

Patent Issued for Rezenopy, the Highest Dosage Naloxone Nasal Spray Approved by the FDA

Takeaways From the 2025 Southern Florida Psychiatry Conference

APSARD 2026: 5 Presentations to Look Out For